Hims & Hers Health (NYSE: HIMS)
Hims & Hers Health Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Hims & Hers Health Company Info
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
News & Analysis
Hims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth Stock
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash
Best Russell 2000 ETFs to Buy in 2025
If you want exposure to hundreds of small-cap stocks, the easiest way is with a Russell 2000 ETF.
What Is the Russell 2000 Stock Market Index?
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies.
Massive News for Hims & Hers Stock Investors!
Down Over 30%, What's Going on With Hims & Hers stock?
Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity?
Valuation
Podcast Episodes
This Weight Loss Partnership Was a Short One
None
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.
A New Name in Weight Loss Drugs
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.